[go: up one dir, main page]

AU1067200A - Pharmaceutical conjugates comprising two active agents - Google Patents

Pharmaceutical conjugates comprising two active agents

Info

Publication number
AU1067200A
AU1067200A AU10672/00A AU1067200A AU1067200A AU 1067200 A AU1067200 A AU 1067200A AU 10672/00 A AU10672/00 A AU 10672/00A AU 1067200 A AU1067200 A AU 1067200A AU 1067200 A AU1067200 A AU 1067200A
Authority
AU
Australia
Prior art keywords
active agents
pharmaceutical conjugates
conjugates
pharmaceutical
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10672/00A
Inventor
Nicola Jane Church
Roy Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU1067200A publication Critical patent/AU1067200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10672/00A 1998-12-17 1999-11-15 Pharmaceutical conjugates comprising two active agents Abandoned AU1067200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827813.8A GB9827813D0 (en) 1998-12-17 1998-12-17 Pharmaceutical conjugates
GB9827813 1998-12-17
PCT/GB1999/003801 WO2000035487A1 (en) 1998-12-17 1999-11-15 Pharmaceutical conjugates comprising two active agents

Publications (1)

Publication Number Publication Date
AU1067200A true AU1067200A (en) 2000-07-03

Family

ID=10844425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10672/00A Abandoned AU1067200A (en) 1998-12-17 1999-11-15 Pharmaceutical conjugates comprising two active agents

Country Status (3)

Country Link
AU (1) AU1067200A (en)
GB (1) GB9827813D0 (en)
WO (1) WO2000035487A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent
CN108267577B (en) * 2018-01-15 2020-10-09 广州市妇女儿童医疗中心 An EV71 virus IgA antibody detection test strip

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69731985T2 (en) * 1996-10-21 2005-12-29 Quadrant Drug Delivery Ltd., Ruddington BLANK SPARE PARTS AND SUITABLE CONJUGATION MANUFACTURING PROCESS
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate

Also Published As

Publication number Publication date
GB9827813D0 (en) 1999-02-10
WO2000035487A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU5259100A (en) Medicament
SG115489A1 (en) Pharmaceutically active morpholinol
AU5387898A (en) Pharmaceutical agents
AU4328800A (en) Pharmaceutical formulation
AU1409100A (en) Drugs
AU6715600A (en) Pharmaceutical formulations
AU5965399A (en) Pharmaceutically active composition
AU2451500A (en) Therapeutic agents
AU4977300A (en) Pharmaceutical formulations
AU5973600A (en) Therapeutic agents
AU1385801A (en) Pharmaceutical formulations
AU1800100A (en) Medicinal preparations
AU3839900A (en) Pharmaceutical formulation
AU5182099A (en) Pharmaceutical formulation
AU1067200A (en) Pharmaceutical conjugates comprising two active agents
AU5429699A (en) Drug targeting
AU1388501A (en) Pharmaceutical formulation
AU2279800A (en) Pharmaceutical preparation
AU4504201A (en) Drug preparations
AU6150200A (en) Therapeutic agents
AUPP574298A0 (en) Pharmaceutical preparation
AU5817400A (en) Therapeutic agents
AUPP458098A0 (en) Pharmaceutical agents
AUPQ070099A0 (en) Pharmaceutical agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase